A critical discovery in cancer research is arising with the use of mini-antibodies to re-engage dysfunctional p53. This essential tumor suppressor protein is frequently inactivated in many forms of cancer, causing https://sites2000.com/story11814271/nanobodies-revive-tumor-suppressor-p53-a-potential-approach-for-cancer-therapy